Evidence map›Paper›PMID 40722681›Full record

ArticleBiomedicines2025

Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications.

Wojciech Szlasa, Monika Kisielewska, Anna Sobczyńska-Konefał, Emilia Jaskuła, Monika Mordak-Domagała, Jacek Kwiatkowski, Katarzyna Tatara, Agnieszka Kuś, Mateusz Sawicki, Izabela Dereń-Wagemann and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wojciech SzlasaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Monika KisielewskaDepartment of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wrocław, Poland.ORCID 0009-0002-8166-4353
Anna Sobczyńska-KonefałLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Emilia JaskułaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.ORCID 0000-0002-4894-7522
Monika Mordak-DomagałaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Jacek KwiatkowskiLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Katarzyna TataraLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Agnieszka KuśLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Mateusz SawickiLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Izabela Dereń-WagemannLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Mariola SędzimirskaLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Ugo GiordanoLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.
Jarosław DybkoLower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wrocław, Poland.ORCID 0000-0003-3555-2887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD20CLLobinutuzumabrituximabvenetoclax

Identifiers

PMID40722681
PMCPMC12292417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.